0.914

1.79% -0.0167

After Hours: .89 -0.024 -2.63%

Oragenics Inc (OGEN)

Overview News Price History Discussions Forecast Stock Split

Oragenics Inc stock is traded at $0.914, with a volume of 400.30K. It is down -1.79% in the last 24 hours and down -21.21% over the past month. Oragenics, Inc. focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring dietary substance for weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay. Oragenics, Inc. has collaboration agreements with Intrexon Corporation and its subsidiary, Intrexon Actobiotics NV to develop AG013 as a potential treatment of oral mucositis for cancer patients. It also has license agreements with LPThera LLC to develop LPT3-04, a weight-loss product candidate; and Texas A&M University System for access to new homologs of the lantibiotic Mutacin 1140 (MU1140) and other lantibiotics, as well as holds licenses from the University of Florida Research Foundation, Inc. for MU1140 product candidates. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.

Previous Close:

$0.9307

Open:

$0.9441

24h Volume:

400.30K

Relative Volume:

3.08

Market Cap:

$3.81M

Revenue:

Net Income/Loss:

$-20.26M

P/E Ratio:

-0.107

EPS:

-8.54

Net Cash Flow:

$-8.25M

1W Performance:

+3.45%

1M Performance:

-21.21%

6M Performance:

-80.26%

1Y Performance:

-90.65%

1-Day Range:

$0.863

$0.985

1-Week Range:

$0.863

$1.00

52-Week Range:

$0.82

$18.90

Oragenics Inc Stock (OGEN) Company Profile

Name

Oragenics Inc

Sector

Healthcare (1123)

Industry

Biotechnology (627)

Phone

813-286-7900

Address

4902 Eisenhower Boulevard, Suite 125, Tampa, FL

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

OGEN's Discussions on Twitter

Compare OGEN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OGEN Oragenics Inc	0.914	3.88M	0	-20.26M	-8.25M	-8.54
VRTX Vertex Pharmaceuticals Inc	452.04	113.14B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.29	78.49B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	877.94	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	397.55	54.51B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	197.01	41.64B	447.02M	-1.18B	-906.14M	-6.1812

Oragenics Inc Stock (OGEN) Latest News

Dec 05, 2025

Oragenics (NYSEAMERICAN:OGEN) Shares Down 1.5% – What’s Next? - Defense World

Dec 05, 2025

Dec 04, 2025

Why Oragenics Inc. stock attracts wealthy investorsAnalyst Upgrade & Consistent Profit Focused Trading Strategies - Newser

Dec 04, 2025

Will Oragenics Inc. stock benefit from infrastructure billJuly 2025 Market Mood & Weekly Momentum Picks - Newser

Dec 04, 2025

Dec 03, 2025

Is Oragenics Inc. stock attractive post correctionJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - Newser

Dec 03, 2025

Why Oragenics Inc. stock is a strong buy callJuly 2025 Review & Accurate Intraday Trade Tips - Newser

Dec 03, 2025

Dec 02, 2025

Downgrade Watch: Can Oragenics Inc stock deliver 10 annual returnsQuarterly Trade Summary & Daily Profit Focused Stock Screening - BỘ NỘI VỤ

Dec 02, 2025

Can Oragenics Inc. stock hit record highs againWeekly Stock Analysis & Smart Investment Allocation Insights - Newser

Dec 02, 2025

Nov 28, 2025

Will Oragenics Inc. stock deliver shareholder valueGlobal Markets & Daily Profit Focused Stock Screening - moha.gov.vn

Nov 28, 2025

Nov 27, 2025

Will Oragenics Inc. stock hit Wall Street targets2025 Top Gainers & Short-Term Trading Opportunity Alerts - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025